Newsletter

Russian Standard Vodka

Total Labels 1
Approved 1
Expired 0

Gancia USA, ROUST USA, INC. — NEW YORK, NY

Italy

About Russian Standard Vodka

Russian Standard Vodka is a vodka product registered with the Alcohol and Tobacco Tax and Trade Bureau. According to TTB records, the brand originates from Italy and is classified as vodka in the 80-89 proof category. The spirit is listed in the Formulated Beverage classification system. The brand maintains a single distinct product offering within its current portfolio. TTB label approval records show one total approval on file for Russian Standard Vodka, with the most recent approval activity documented in 2026. The brand represents one entry within the broader vodka category available through spirits retailers and reference databases. As a vodka product meeting federal proof standards, Russian Standard Vodka falls within the regulated spirits category overseen by TTB authorities. The Italian origin designation places this product within the international vodka market segment. Distribution and availability of Russian Standard Vodka follow standard TTB-approved labeling and classification protocols. The single product group structure indicates a focused brand approach within the competitive vodka marketplace.

Filter by:
Displaying 1 results
Label Name Spirit Type Status Approval Date Producer
Vodka 80-89 Proof Fb
Russian Standard Vodka

VODKA 80-89 PROOF FB

Vodka 80-89 Proof Fb Approved 2026-01-14 Gancia USA, ROUST USA, INC.

Page 1 of 1

1

Russian Standard Vodka at a Glance

Russian Standard Vodka has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof Fb. Labels approved between 2026-01-14 and 2026-01-14. Produced in Italy.

All information sourced from public TTB records.

Are you the owner or distributor of Russian Standard Vodka?

Claim this brand listing to update information or get featured. Contact [email protected].

Produced At

Gancia USA, Roust USA, INC.

Related Brands

Related Questions

Browse All Labels

Stay informed

Newsletter coming soon.

Follow us on X for new approvals, launches, and industry intelligence.